The device, an extension of the company’s Airos 8 model that has provided treatment for patients since 2018, also adds Peristaltic Mode functionality for upper body treatment. The truncal garment is designed in a pants-like configuration, which is ideal for patients with lymphedema in the lower legs, back, abdomen, pelvic, and hip areas. The Airos 8P pneumatic compression device and new truncal garment line will allow Airos Medical to treat more of these patients. Millions more suffer from chronic venous insufficiency (CVI), a venous disorder in which vein valves in the legs do not function properly preventing or limiting blood flow back to the heart, the company said in a press release. Various estimates indicate that 5-10 million Americans or more have lymphedema, a chronic condition in which damaged or removed lymph nodes creates fluid build-up and swelling in various areas of the body. The clearance also allows Airos to provide larger compression therapy garments including lower truncal garments to treat abdominal swelling. Airos Medical, a medical technology manufacturer and designer specialising in compression therapy devices that treat lymphedema and venous complications, has announced it has received the US Food and Drug Administration (FDA) 510(k) clearance to market its Airos 8P Sequential Compression Therapy device and garment system. It is a pneumatic compression device that delivers intermittent compression to the affected areas of the body through specialised garments that wrap around the limbs and trunk. US’ Airos Medical receives FDA clearance to market therapy deviceĪiros Medical's Airos 8P Sequential Compression Therapy device and garment system is a medical device designed to treat lymphedema and chronic venous insufficiency (CVI).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |